✦ LIBER ✦

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Scribed by Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Barca; Marcos González; Christelle Ferrà; Eugenia Abella; Julio Delgado; Jose A. Garcia-Marco; Yolanda Gonzalez; Felix Carbonell; Secundino Ferrer; Encarna Monzo; Isidro Jarque; Ana Muntanola; Mireia Constants; Lourdes Escoda; Emili Montserrat

Book ID: 119218984
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 250 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.194

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB